פריוויג'ן

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

IMMUNOGLOBULINS, NORMAL HUMAN

可用日期:

CSL BEHRING LTD., ISRAEL

ATC代码:

J06BA02

药物剂型:

תמיסה לאינפוזיה

组成:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

给药途径:

תוך-ורידי

处方类型:

מרשם נדרש

厂商:

CSL BEHRING AG, SWITZERLAND

治疗组:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

治疗领域:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

疗效迹象:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

授权日期:

2016-06-30